Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Naive Patients”

Showing 20 of 0 results

Not applicableApproved For MarketingNCT01931306
What this trial is testing

Expanded Access Study of Afatinib in Treatment-naive or Chemotherapy Pre-treated Patients With Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim
Large-scale testing (Phase 3)Study completedNCT00318123
What this trial is testing

Study to Evaluate the Effectiveness of ABC+3TC +EFV in Once-Daily Regimens Versus KLT in Twice-Daily Regimens in Naive HIV Patients

Who this might be right for
HIV Infections
Germans Trias i Pujol Hospital 126
Testing effectiveness (Phase 2)Study completedNCT00887120
What this trial is testing

Dose Reduction of Lopinavir in Children

Who this might be right for
HIV Infections
The HIV Netherlands Australia Thailand Research Collaboration 24
Not applicableNot Yet RecruitingNCT07521124
What this trial is testing

ABC Maintenance Therapy for AML

Who this might be right for
Acute Myeloid Leukemia (AML) in Remission
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 104
Large-scale testing (Phase 3)Study completedNCT00101803
What this trial is testing

Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Drug Naive Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Novartis Pharmaceuticals 527
Testing effectiveness (Phase 2)Study completedNCT00940797
What this trial is testing

Effect of DMMET-01 on Insulin Sensitivity in Naive Type 2 Diabetes Patients (CLAMP)

Who this might be right for
Diabetes Type 2
Laboratorios Silanes S.A. de C.V. 20
Large-scale testing (Phase 3)Study completedNCT06593938
What this trial is testing

Evaluate the Efficacy and Safety of Oral HRS-5965 in Adult Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Who Are Naive to Complement Inhibitor Therapy

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria
Chengdu Suncadia Medicine Co., Ltd. 76
Post-approval studies (Phase 4)Study completedNCT00545233
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) With or Without Pioglitazone in Treatment-Naive Patients With Chronic Hepatitis C and Insulin Resistance.

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 155
Large-scale testing (Phase 3)Study completedNCT02951533
What this trial is testing

Compare the Efficacy of Guselkumab to Fumaric Acid Esters for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Janssen-Cilag G.m.b.H 119
Not applicableUnknownNCT04124107
What this trial is testing

Unfavorable MRI But Favorable 68Ga-PSMA PET/MRI for Primary Prostate Cancer Detection

Who this might be right for
Prostate Neoplasm
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 50
Post-approval studies (Phase 4)Study completedNCT01438814
What this trial is testing

Linagliptin in Combination With Metformin in Treatment Naive Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic Control

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 689
Testing effectiveness (Phase 2)UnknownNCT05262985
What this trial is testing

Durvalumab (MEDI4736) Plus Platinum-based Chemotherapy in Advanced LCNEC: a Pilot Phase II Study

Who this might be right for
Patients With Advanced Treatment Naive LCNEC
Elizabeth Dudnik 22
Large-scale testing (Phase 3)UnknownNCT00006208
What this trial is testing

A Comparison of Emtricitabine and Stavudine Used With Didanosine Plus Efavirenz in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
Triangle Pharmaceuticals
Testing effectiveness (Phase 2)UnknownNCT01067417
What this trial is testing

Evaluation of the Efficacy of Hydroxychloroquine in Decreasing Immune Activation in Asymptomatic HIV-infected Patients

Who this might be right for
HIV Infections
Medical Research Council 83
Testing effectiveness (Phase 2)Study completedNCT00534352
What this trial is testing

Evaluate the Pharmacokinetic Profile (How the Body Absorbs, Distributes, Metabolizes and Eliminates a Drug) of TMC125 Plus Tenofovir/Emtricitabine Once Daily With or Without Darunavir/r Once Daily in Antiretroviral (ARV) Naive HIV-1 Patients (Patients Have Never Received ARV Treatment).

Who this might be right for
HIV-1 Infection
Tibotec, Inc 23
Testing effectiveness (Phase 2)UnknownNCT01441349
What this trial is testing

Irinotecan/Cisplatin With or Without Simvastatin in Chemo-naive Patients With Extensive Disease-small Cell Lung Cancer

Who this might be right for
Small Cell Lung Carcinoma
National Cancer Center, Korea 192
Testing effectiveness (Phase 2)Study completedNCT00095667
What this trial is testing

Lapatinib in Treating Patients With Recurrent or Metastatic Prostate Cancer

Who this might be right for
Recurrent Prostate CancerStage IV Prostate Cancer
National Cancer Institute (NCI) 41
Large-scale testing (Phase 3)Study completedNCT00966160
What this trial is testing

CD4 Cell Recovery in HIV-1 Patients Comparing 2 Treatment Regimes

Who this might be right for
Acquired Immunodeficiency SyndromeHIV Infections
University of Cologne 215
Post-approval studies (Phase 4)UnknownNCT00135460
What this trial is testing

Comparing a Nucleoside-Analogue-Sparing Regimen and a Protease-Inhibitor-Sparing Regimen in HIV Infected Patients

Who this might be right for
HIV-Associated Lipodystrophy Syndrome
Danish HIV Research Group 100
Post-approval studies (Phase 4)Ended earlyNCT01068873
What this trial is testing

Kaletra and Maraviroc in Antiretroviral Therapy (ART)-Naive Patients (KALMAR Study)

Who this might be right for
HIV Infections
Temple University 1
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation